None listed
Conditions
Brief summary
This study looks the effectiveness of a web-based toolkit for young women, explaining how to reduce the risks of cervical cancer. You can join this study if you are a woman aged 19-26 years, have access to the internet and are considering a GP visit to discuss cervical cancer prevention. Trial details Participants visiting their GP will be divided into two groups. One group will be provided with an online ‘decision tool’ prior to the consultation. The other group will have a standard consultation only. The web-based toolkit will be a one-stop source of information for the latest information about cervical cancer, and will also provide feedback on consultation length, HPV knowledge, etc. Women will ideally learn to access the tool before their Pap test every two years. The aim is see whether the toolkit is effective in increasing the proportion of young women adequately informed about HPV without increasing the consultation time. The preparation of patients before the consultation is an important model that could be transferable to other aspects of general practice.
Interventions
Women in the intervention group will be receiving an online decision tool prior to the consultation. They will be sent a study ID to access the online tool as soon as they register to the trial. They can visit the website as many times as they like before their Pap visit. The tool will be a one-stop source of information for cervical cancer prevention.It will incorporate evidence-based information cervical cancer risk reduction options such as lifestyle factors, Pap smear (conventional and LBC),
Women in the intervention group will be receiving an online decision tool prior to the consultation. They will be sent a study ID to access the online tool as soon as they register to the trial. They can visit the website as many times as they like before their Pap visit. The tool will be a one-stop source of information for cervical cancer prevention.It will incorporate evidence-based information cervical cancer risk reduction options such as lifestyle factors, Pap smear (conventional and LBC), HPV vaccination. The tool will also use epidemiological estimates of cumulative risks and text based information with quantitative estimates of outcomes. We will show women in absolute terms the chances of low-grade intraepithelial lesion (LSIL), high-grade intraepithelial lesion (HSIL and cervical cancer at their age and their reduction in risk with Pap smear, Liquid based cytology (LBC), Human papillomavirus (HPV) vaccine and lifestyle changes (smoking cessation, condom use...). The overall duration of the study will be 6 months. Two months for recruiting participants, 2 months for collecting data and 2 months follow up for participants who have not attended their Pap smear consultation.
Sponsors
Lyndal Trevena
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
19 Years to 26 Years
Healthy volunteers
Yes
Inclusion criteria
19-26 year old women living in Australia who have internet access and a reasonnable command of the english language and who are considering to have cervical cancer prevention visit.
Exclusion criteria
No internet access , poor english, younger than 19 years or older than 26 years.
Outcome results
None listed